MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    RBD increase non-motor symptom in Parkinson’s disease

    Y. Wu, Y. Liu, X. Zhu, X. Zhang, S. Kuo, W.G. Ondo (Shanghai, People's Republic of China)

    Objective: To investigate the relationship between the RBD and other non-motor symptoms in Parkinson's disase. Background: Rapid eye movement sleep behavior disorder (RBD) is frequent…
  • 2016 International Congress

    Gait impairment is more than a motor symptom in Parkinson’s disease

    H.F. Chan, D.K.W. Chau, T. Fung, Y.F. Cheung, W.C. Fong (Hong Kong, Hong Kong)

    Objective: To examine the relationship of gait impairment of Parkinson's disease (PD) patients with different clinical factors including motor function, non-motor function and cognitive function.…
  • 2016 International Congress

    Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial

    J.L. Purks, A. Zeymo, N.M. Shara, K.E. Anderson, I. Shoulson (Washington, DC, USA)

    Objective: Examine the relationship between Trails Making Test B (TMT-B) performance and bothersome cognitive complaints among Huntington Disease (HD) research participants in the REACH2HD randomized-controlled…
  • 2016 International Congress

    Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients

    M. Trošt, S. Brezovar, C.C. Tang, D. Eidelberg, N. Zupancic Kriznar, M. Gregoric Kramberger, P. Tomše, Z. Pirtošek (Ljubljana, Slovenia)

    Objective: To measure the expression of the Parkinson's disease related cognitive pattern (PDCP) in 18F-FDG-PET brain images of Parkinson's disease (PD) patients and healthy controls…
  • 2016 International Congress

    Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia

    E.P.F. Resende, P. Caramelli, F.E.C. Cardoso, H.C. Guimarães, M. Hornberger, M. Bertoux, A.L. Teixeira, L. Cruz de Souza (Belo Horizonte, Brazil)

    Objective: To explore the cognitive profile of PSP patients in tests of social cognition and to compare their performance to patients with behavioural variant frontotemporal…
  • 2016 International Congress

    Speech prosody impairment predicts cognitive decline in Parkinson’s disease

    I. Rektorova, J. Mekyska, E. Janousova, M. Kostalova, M. Mrackova, I. Eliasova, D. Berankova, R. Marecek (Brno, Czech Republic)

    Objective: We assessed whether baseline speech prosodic parameters, alone or in combination with other predominantly non-dopaminergic symptoms may predict global cognitive decline as measured by…
  • 2016 International Congress

    Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

    R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)

    Objective: To evaluate the correlation between cognitive and functional performance of Parkinsonian with normal Mini-Mental State Examination (MMSE), and demographic variables, motor impairment, neuropsychiatric disorders…
  • 2016 International Congress

    Scores and dimensions to assess cognitive impairment in Parkinson’s disease

    I. Liepelt-Scarfone, S. Gräber, A. Pilotto, D. Blum, M. Fruhmann Berger, D. Berg (Tübingen, Germany)

    Objective: To provide inside into the nature of cognitive deterioration in Parkinson's disease dementia (PDD) and to define a score discriminating PDD patients from non-demented…
  • 2016 International Congress

    Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

    M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

    Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…
  • 2016 International Congress

    Affective theory of mind in Parkinson’s disease

    A.M. Hammad, S. Ghozy, S.I. El-Jaafary (Cairo, Egypt)

    Objective: The aim of this study is to assess the hypothesis that patients with PD may show difficulties in tasks related to affective theory of…
  • « Previous Page
  • 1
  • …
  • 114
  • 115
  • 116
  • 117
  • 118
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley